Tofacitinib Extended Release Tablets

Tofacitinib Extended-Release Tablets: FASTNIB-FORTE TAB is made up of the drug named Tofacitinib, which is a Janus kinase inhibitor that is used in the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Rheumatoid arthritis is a disease where the body's immune system mistakenly attacks its tissues, causing pain and damage to the joints. Psoriatic arthritis is a condition that causes inflammation in the joints and is often linked with psoriasis. Ulcerative colitis is an inflammatory disease that affects the large intestine. This medicine works by blocking the actions of Janus kinase, which is an enzyme that helps in reducing inflammation and joint pain damage in rheumatoid arthritis.

Uses of Tofacitinib Extended-Release Tablets

• Tofacitinib Extended-Release Tablets belong to the group of Janus kinase inhibitor medicines that are used in the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
• This medicine works by blocking the Janus kinase enzyme, reducing inflammation, and treating the symptoms related to rheumatoid and psoriatic arthritis.
• Tofacitinib is used for people with moderate to severe rheumatoid arthritis and psoriatic arthritis if they cannot tolerate or do not respond well to methotrexate or other similar medications.

Precaution to use for Tofacitinib Extended-Release Tablets

• Do not take it if you are allergic to Tofacitinib Extended-Release Tablets; you need to have the doctor's advice before taking this medicine.
• If you have a severe infection, active tuberculosis, bloodstream infection, or any other liver condition like cirrhosis, then you should avoid taking Tofacitinib Extended-Release Tablets.
• If the patient is pregnant or breastfeeding, then they should inform their doctor first.
• Also consult with your doctor if this medicine affects the immune system or has a history of tuberculosis, liver problems, hepatitis B/C, cancer, and skin cancer.
• If your white blood cell and red blood cell counts are low, then you should avoid taking Tofacitinib Extended-Release Tablets.
• This medicine is not recommended for patients who are below 18 years of age.
• You must tell your doctor all of your medical history and the medicine that you are taking with Tofacitinib Extended-Release Tablets that can minimize the side effects.
• Here is the list of the drugs that may interact with Tofacitinib Extended-Release Tablets:

Directions to use for Tofacitinib Extended-Release Tablets

Possible Side Effects of Tofacitinib Extended-Release Tablets

• Headache
• Diarrhea
• Vomiting
• Nausea
• Upper respiratory tract infection
• Cold
• High blood pressure